The HealthTech Venture Network is excited to welcome Dr. Laura I. Davis – Managing Director of Golden Seeds angel investor group – to our 2017 Conference lineup, as moderator to our “Greater Value of Investing in Female Tech Founders Round-Table.” Held from 1:30 p.m. – 2:30 p.m., this discussion explores the greater value of investing in female tech founders in the healthcare technology industry.
Dr. Davis is an early stage investor who is interested in helping entrepreneurial life scientists translate their work from the bench to the marketplace.
Dr. Davis did her graduate training at Rockefeller University, and her postdoctoral work at the Whitehead Institute, where she was a Helen Hay Whitney Fellow and a Lucille P. Markey Scholar. As a Howard Hughes Assistant Investigator at Duke University Medical School and later at the Rosenstiel Center at Brandeis University, she oversaw an active laboratory using molecular genetics to study cellular function, and authored numerous publications. She has served on several NIH and NSF grant review committees, and as a reviewer for numerous scientific journals. She has taught genetics and cell biology to undergraduate, graduate and medical students, and was also involved in teaching molecular biology to the Knight science journalism Fellows at MIT.
Dr. Davis is currently a managing director of Golden Seeds, an angel investor group focusing on women-owned, women-led companies that provides early stage and growth capital across all sectors to women entrepreneurs. She is on the board of directors of Day Zero Diagnostics.
Register now for a day of innovation and progressive healthtech discussion with a spotlight on female entrepreneurs in the industry. Extended ticket sales are available until October 5th.